000403.SZライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (26 4月 2024 @ 16:04):

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China...

Stats
本日の出来高	3.46M
平均出来高	5.61M
時価総額	21.75B
EPS	CNY0.250 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	38.79
ATR14	CNY0.0320 (0.11%)

ボリューム相関

長: 0.07 (neutral)

短: 0.85 (strong)

Signal:(63.153) Same movement expected

Pacific Shuanglin 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Pacific Shuanglin 相関 - 通貨/商品

0.18
( neutral )

0.32
( neutral )

0.00
( neutral )

0.31
( neutral )

0.33
( neutral )

-0.28
( neutral )

Pacific Shuanglin 財務諸表

Annual	2023
収益:	CNY2.33B
総利益:	CNY2.33B (100.00 %)
EPS:	CNY0.840

FY	2023
収益:	CNY2.33B
総利益:	CNY2.33B (100.00 %)
EPS:	CNY0.840

FY	2022
収益:	CNY2.41B
総利益:	CNY1.25B (52.13 %)
EPS:	CNY0.800

FY	2021
収益:	CNY1.97B
総利益:	CNY908.43M (46.07 %)
EPS:	CNY0.554

Financial Reports:

No articles found.

Pacific Shuanglin

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.